| Dr Cynthia Lyn Costa, MD | |
|
2790 Clay Edwards Dr Ste 1235, North Kansas City, MO 64116-3276 | |
| (816) 472-5157 | |
| (816) 472-7201 |
| Full Name | Dr Cynthia Lyn Costa |
|---|---|
| Gender | Female |
| Speciality | Neurology |
| Experience | 13 Years |
| Location | 2790 Clay Edwards Dr Ste 1235, North Kansas City, Missouri |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1649558461 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| North Kansas City Hospital | North kansas city, MO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Meritas Health Corporation | 6305748153 | 365 |
News Archive
A national panel of pain management experts representing the American Pain Society (APS) and the American Academy of Pain Medicine (AAPM) has published the first comprehensive, evidence-based clinical practice guideline to assist clinicians in prescribing potent opioid pain medications for patients with chronic non-cancer pain.
Ipsen (Euronext:IPN), an innovation-driven global specialty pharmaceutical Group and Debiopharm Group (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs, announced today the signature of an agreement under which Debiopharm is granted an exclusive worldwide license to develop and commercialise Ipsen's first-in-class inhibitor of the CDC25 phosphatase enzyme (now Debio 0931), for the treatment of various human cancers.
Patients who are evaluated for liver diseases such as hepatitis C (HCV) are typically recommended for liver biopsy to determine the extent of disease progression. For patients who question whether less invasive testing is available, clinicians now have alternatives options to consider. Elastography and serum markers are two such diagnostic options reviewed in an editorial published in the June issue of Hepatology, a journal of the American Association for the Study of Liver Diseases.
"The cholera bacterium has undergone important mutations in recent years, causing longer outbreaks of the disease with increased fatalities, researchers reported on Wednesday," Reuters reports. "In a package of papers published in the journal PLoS Neglected Tropical Diseases, they said mass vaccinations should be considered as a solution even after outbreaks have begun," the news service writes (Lyn, 1/26).
› Verified 1 days ago
| Entity Name | Meritas Health Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801875091 PECOS PAC ID: 6305748153 Enrollment ID: O20040122001058 |
News Archive
A national panel of pain management experts representing the American Pain Society (APS) and the American Academy of Pain Medicine (AAPM) has published the first comprehensive, evidence-based clinical practice guideline to assist clinicians in prescribing potent opioid pain medications for patients with chronic non-cancer pain.
Ipsen (Euronext:IPN), an innovation-driven global specialty pharmaceutical Group and Debiopharm Group (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs, announced today the signature of an agreement under which Debiopharm is granted an exclusive worldwide license to develop and commercialise Ipsen's first-in-class inhibitor of the CDC25 phosphatase enzyme (now Debio 0931), for the treatment of various human cancers.
Patients who are evaluated for liver diseases such as hepatitis C (HCV) are typically recommended for liver biopsy to determine the extent of disease progression. For patients who question whether less invasive testing is available, clinicians now have alternatives options to consider. Elastography and serum markers are two such diagnostic options reviewed in an editorial published in the June issue of Hepatology, a journal of the American Association for the Study of Liver Diseases.
"The cholera bacterium has undergone important mutations in recent years, causing longer outbreaks of the disease with increased fatalities, researchers reported on Wednesday," Reuters reports. "In a package of papers published in the journal PLoS Neglected Tropical Diseases, they said mass vaccinations should be considered as a solution even after outbreaks have begun," the news service writes (Lyn, 1/26).
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Cynthia Lyn Costa, MD 2790 Clay Edwards Dr Ste 1235, North Kansas City, MO 64116-3276 Ph: (816) 472-5157 | Dr Cynthia Lyn Costa, MD 2790 Clay Edwards Dr Ste 1235, North Kansas City, MO 64116-3276 Ph: (816) 472-5157 |
News Archive
A national panel of pain management experts representing the American Pain Society (APS) and the American Academy of Pain Medicine (AAPM) has published the first comprehensive, evidence-based clinical practice guideline to assist clinicians in prescribing potent opioid pain medications for patients with chronic non-cancer pain.
Ipsen (Euronext:IPN), an innovation-driven global specialty pharmaceutical Group and Debiopharm Group (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs, announced today the signature of an agreement under which Debiopharm is granted an exclusive worldwide license to develop and commercialise Ipsen's first-in-class inhibitor of the CDC25 phosphatase enzyme (now Debio 0931), for the treatment of various human cancers.
Patients who are evaluated for liver diseases such as hepatitis C (HCV) are typically recommended for liver biopsy to determine the extent of disease progression. For patients who question whether less invasive testing is available, clinicians now have alternatives options to consider. Elastography and serum markers are two such diagnostic options reviewed in an editorial published in the June issue of Hepatology, a journal of the American Association for the Study of Liver Diseases.
"The cholera bacterium has undergone important mutations in recent years, causing longer outbreaks of the disease with increased fatalities, researchers reported on Wednesday," Reuters reports. "In a package of papers published in the journal PLoS Neglected Tropical Diseases, they said mass vaccinations should be considered as a solution even after outbreaks have begun," the news service writes (Lyn, 1/26).
› Verified 1 days ago
Jeffrey W Thornton, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2790 Clay Edwards Dr, Suite 1235, North Kansas City, MO 64116 Phone: 816-472-5157 Fax: 816-472-7201 | |
Dr. Shannon Kohake, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2790 Clay Edwards Dr Ste 1235, North Kansas City, MO 64116 Phone: 816-472-5157 Fax: 816-472-7200 | |
Jay Gordon Robinson, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2790 Clay Edwards Dr, Suite 1235, North Kansas City, MO 64116 Phone: 816-472-5157 Fax: 816-472-7201 | |
Robert Louis Satake, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 2790 Clay Edwards Dr, Suite 500, North Kansas City, MO 64116 Phone: 816-472-5157 Fax: 816-472-7201 | |
Fred L Sachen, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2790 Clay Edwards Dr, Suite 500, North Kansas City, MO 64116 Phone: 816-472-5157 Fax: 816-472-7201 | |
Scott Michael Shorten, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2790 Clay Edwards Dr, Suite 1235, North Kansas City, MO 64116 Phone: 816-472-5157 Fax: 816-472-7201 |